Methylstenbolone
 | |
| Clinical data | |
|---|---|
| Other names | M-Sten, Methyl-Sten, Ultradol; NSC-74234 |
| Routes of administration | Oral |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C21H32O2 |
| Molar mass | 316.485 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methylstenbolone (nicknames M-Sten, Methyl-Sten, Ultradrol), also known as 2,17α-dimethyl-4,5α-dihydro-δ1-testosterone (2,17α-dimethyl-δ1-DHT) or as 2,17α-dimethyl-5α-androst-1-en-17β-ol-3-one, is an orally active anabolic-androgenic steroid (AAS) and 17α-methylated derivative of dihydrotestosterone (DHT) that has never been introduced for medical use.[1][2][3] It is a designer steroid and has been sold "over-the-counter" via the internet as a "dietary/nutritional supplement".[1][2][3] Methylstenbolone is the 17α-methylated derivative of stenbolone, which is similarly androgenic but only about half as anabolic,[citation needed] as well as the δ1-isomer of methasterone (2α,17α-dimethyl-DHT).
See also
References
- ^ a b Rahnema CD, Crosnoe LE, Kim ED (2015). "Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem". Andrology. 3 (2): 150–5. doi:10.1111/andr.307. PMID 25684733.
- ^ a b Kimergård A, Walker C, Cowan D (2015). "Potent and untested drugs sold as "dietary supplements"". BMJ. 351: h4181. PMID 26245332.
- ^ a b Joseph JF, Parr MK (2015). "Synthetic androgens as designer supplements". Curr Neuropharmacol. 13 (1): 89–100. doi:10.2174/1570159X13666141210224756. PMC 4462045. PMID 26074745.
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |